UBS Group
NUVL

UBS Group’s Nuvalent NUVL Stock Holding History

UBS Group’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.2M Sell
363,098
-35,955
-9% -$3.66M 0.01% 1937
2025
Q4 		$40.1M Buy
399,053
+185,932
+87% +$18.3M 0.01% 1854
2025
Q3 		$18.4M Buy
213,121
+76,377
+56% +$6.04M ﹤0.01% 2663
2025
Q2 		$10.4M Buy
136,744
+27,265
+25% +$2M ﹤0.01% 3045
2025
Q1 		$7.76M Buy
109,479
+54,639
+100% +$4.27M ﹤0.01% 3317
2024
Q4 		$4.29M Buy
54,840
+8,226
+18% +$768K ﹤0.01% 3991
2024
Q3 		$4.77M Sell
46,614
-6,781
-13% -$562K ﹤0.01% 3121
2024
Q2 		$4.05M Sell
53,395
-30,623
-36% -$2.18M ﹤0.01% 3073
2024
Q1 		$6.31M Buy
84,018
+3,387
+4% +$270K ﹤0.01% 2723
2023
Q4 		$5.93M Buy
80,631
+61,763
+327% +$3.82M ﹤0.01% 2606
2023
Q3 		$867K Sell
18,868
-12,902
-41% -$573K ﹤0.01% 4204
2023
Q2 		$1.34M Buy
31,770
+1,329
+4% +$50.2K ﹤0.01% 3950
2023
Q1 		$794K Sell
30,441
-6,747
-18% -$200K ﹤0.01% 4303
2022
Q4 		$1.11M Buy
+37,188
New +$1.04M ﹤0.01% 3973
2022
Q2 		– Sell
-1,429
Closed -$20K – 10728
2022
Q1 		$20K Buy
1,429
+131
+10% +$1.9K ﹤0.01% 7451
2021
Q4 		$25K Buy
1,298
+486
+60% +$10.8K ﹤0.01% 7589
2021
Q3 		$18K Buy
+812
New +$23.6K ﹤0.01% 7292

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS Group's NUVL Position: Q1 2026 in Review

UBS Group reduced its Nuvalent (NUVL) stake by 9% in Q1 2026, selling an estimated $3.66M and leaving 363,098 shares worth $37.2M. The position accounts for 0.01% of the portfolio, ranked #1937.

UBS Group first reported a position in NUVL in Q3 2021 and has held it in 17 quarters since. The position peaked at $40.1M in Q4 2025. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • UBS Group held 363,098 shares of Nuvalent worth $37.2M as of Q1 2026.
  • UBS Group sold 35,955 Nuvalent shares in Q1 2026, an estimated $3.66M.
  • Nuvalent made up 0.01% of UBS Group's portfolio in Q1 2026, its #1937 holding.
  • UBS Group first reported a position in Nuvalent in Q3 2021 and has held it in 17 quarters since.
  • UBS Group's Nuvalent position peaked at $40.1M in Q4 2025.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.